Prof. Jo Seldeslachts, Ph.D.

Prof. Jo Seldeslachts, Ph.D.

Researcher
Firms and Markets Department

Publications

DIW Discussion Papers 2128 / 2025

Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development

2025| Jan Malek, Jo Seldeslachts, Reinhilde Veugelers
DIW Wochenbericht 37 / 2024

Wichtig ist es, die Innovationseffekte der vielen Übernahmen zu berücksichtigen: Interview

2024| Jo Seldeslachts, Erich Wittenberg
DIW Wochenbericht 37 / 2024

Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten

2024| Jo Seldeslachts, Jan Malek, Melissa Newham, Reinhilde Veugelers
DIW Discussion Papers 2073 / 2024

Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development

2024| Jan Malek, Melissa Newham, Jo Seldeslachts, Reinhilde Veugelers
DIW Wochenbericht 32 / 2023

US-Vermögensverwalter gewinnen in Deutschland an Bedeutung: Interview

2023| Jo Seldeslachts, Erich Wittenberg
Externe Monographien

Common Ownership Patterns in the European Banking Sector –The Impact of the Financial Crisis

Leuven: KU Leuven, [2021], 25 S.
(MSI Discussion Papers ; 2109) | Albert Banal-Estañol, Nuria Boot, Jo Seldeslachts
Externe Monographien

Study on the Impact of State Aid Rules for Banks in Difficulty Prepared: Final Report

Brussels: European Union, 2026, 359 S.
(Clean, Just and Competitive Transition) | Elżbieta Głowicka, Thomas Hildebrand, Jan Málek, Weijie Yan, Lukas Gieser, Vedika Hegde, Zachary Herriges, Giulio Pietrobelli, Giulia Santosuosso, Simon Specht, Francesca Urzi, Thomas David, Michael Tröge, Tomaso Duso, Jo Seldeslachts, José María Martín Flores, Nguyen Manh Hiep, Katarzyna Kwiatkowska, Joanna Rachuba, Dorota Skała, Daniel Streitz
Externe Monographien

Evaluation Support Study for the Revision of the Guidelines on State Aid to Airports and Airlines: Final Report

Brussels: European Union, 2026, 257 S.
(Clean, Just and Competitive Transition) | Thomas Bianchi, Mohamed Lamine Dahmani, Nada Gajić, Rossella Mossucca, Salvatore Nava, Tomaso Duso, Morgane Guignard, Jo Seldeslachts, Lukas Alijošius, Pierre Hausemer, Gilles van Cappellen, Francesca Delfini, Antonio Marsi, Audrey Thenot
Refereed essays Web of Science

One‐Way Versus Two‐Way Postacquisition Integration Efforts: Theory and Evidence

In: Journal of Economics and Management Strategy (2026), im Ersch. [2025-08-20] | Albert Banal-Estañol, Joseph A. Clougherty, Jo Seldeslachts, Florian Szücs
Refereed essays Web of Science

Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry

In: American Economic Journal: Microeconomics 17 (2025), 4, S. 260–327 | Melissa Newham, Jo Seldeslachts, Albert Banal-Estanol

Lectures

Vortrag

M&As: Boost or Barrier to Innovation? New Empirical Methods for the Answer

Jo Seldeslachts
Ulcinj, Montenegro, 29.09.2025 - 03.10.2025| CISS Summer School on Competition and Innovation
Diskussionsteilnahme

Panel Discussion

Jo Seldeslachts
Brüssel, Belgien, 19.05.2025 | Assessing Innovation in Life Sciences: Towards a Robust Economic Framework, Skadden and BRG Consulting
Diskussionsteilnahme

Discussant of "Ohio Rock Salt Procurement Auctions, Bid Preferences, and Competition” Presented by Matthew Weinberg (Ohio State University)

Jo Seldeslachts
Philadelphia, USA, 02.05.2025 - 04.05.2025| 23rd Annual International Industrial Organization Conference: IIOC 2025
Vortrag

Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development

Jo Seldeslachts, Jan Malek, Reinhilde Veugelers
Philadelphia, USA, 02.05.2025 - 04.05.2025| 23rd Annual International Industrial Organization Conference: IIOC 2025
Vortrag

Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development

Jo Seldeslachts, Jan Malek, Reinhilde Veugelers
Amsterdamm, 04.04.2025 | Workshop on Innovation and Markets: Tinbergen Institute

Research Projects

In the media

keyboard_arrow_up
Sorry. no id, no template, no output.